# FDA Inspection 1264269 - Aprecia Pharmaceuticals LLC - March 21, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/aprecia-pharmaceuticals-llc/47a24c0c-b6f4-4239-a0a2-56c8eeb394e0
Source feed: FDA_Inspections

> FDA Inspection 1264269 for Aprecia Pharmaceuticals LLC on March 21, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1264269
- Company Name: Aprecia Pharmaceuticals LLC
- Inspection Date: 2025-03-21
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Cincinnati District Office

## Related Documents

- [FDA Inspection 1092472 - 2019-05-23](https://www.globalkeysolutions.net/records/fda_inspections/aprecia-pharmaceuticals-llc/657e2cf7-1a69-4e18-a8f7-a3f202d445a0)
- [FDA Inspection 1054779 - 2018-05-23](https://www.globalkeysolutions.net/records/fda_inspections/aprecia-pharmaceuticals-llc/422d9046-0c0e-47e2-b156-1fe042ad6213)

Company: https://www.globalkeysolutions.net/companies/aprecia-pharmaceuticals-llc/126049a3-6c3d-4616-8d44-006827a308c3

Office: https://www.globalkeysolutions.net/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22